ProKidney Statistics
Share Statistics
ProKidney has 292.7M
shares outstanding. The number of shares has increased by 2.55%
in one year.
| Shares Outstanding | 292.7M |
| Shares Change (YoY) | 2.55% |
| Shares Change (QoQ) | 0.34% |
| Owned by Institutions (%) | 40.35% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 2,637 |
| FTD / Avg. Volume | 0.32% |
Short Selling Information
The latest short interest is 15.64M, so 12.07% of the outstanding
shares have been sold short.
| Short Interest | 15.64M |
| Short % of Shares Out | 12.07% |
| Short % of Float | 17.21% |
| Short Ratio (days to cover) | 13.5 |
Valuation Ratios
The PE ratio is -2.7 and the forward
PE ratio is -1.26.
ProKidney's PEG ratio is
0.17.
| PE Ratio | -2.7 |
| Forward PE | -1.26 |
| PS Ratio | 2177.35 |
| Forward PS | 4.4 |
| PB Ratio | -0.17 |
| P/FCF Ratio | -1.06 |
| PEG Ratio | 0.17 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for ProKidney.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.93,
with a Debt / Equity ratio of 0.
| Current Ratio | 10.93 |
| Quick Ratio | 10.93 |
| Debt / Equity | 0 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.02 |
| Interest Coverage | -20408.44 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $372.55 |
| Profits Per Employee | $-299,931.37 |
| Employee Count | 204 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -598K |
| Effective Tax Rate | 0.36% |
Stock Price Statistics
The stock price has increased by -79.37% in the
last 52 weeks. The beta is 1.58, so ProKidney's
price volatility has been higher than the market average.
| Beta | 1.58 |
| 52-Week Price Change | -79.37% |
| 50-Day Moving Average | 0.86 |
| 200-Day Moving Average | 1.63 |
| Relative Strength Index (RSI) | 53.03 |
| Average Volume (20 Days) | 819,452 |
Income Statement
In the last 12 months, ProKidney had revenue of 76K
and earned -61.19M
in profits. Earnings per share was -0.48.
| Revenue | 76K |
| Gross Profit | 76K |
| Operating Income | -183.68M |
| Net Income | -61.19M |
| EBITDA | -159.59M |
| EBIT | -163.92M |
| Earnings Per Share (EPS) | -0.48 |
Full Income StatementBalance Sheet
The company has 99.12M in cash and 3.24M in
debt, giving a net cash position of 95.88M.
| Cash & Cash Equivalents | 99.12M |
| Total Debt | 3.24M |
| Net Cash | 95.88M |
| Retained Earnings | -1.2B |
| Total Assets | 441.07M |
| Working Capital | 359.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -126.35M
and capital expenditures 0, giving a free cash flow of -155.86M.
| Operating Cash Flow | -126.35M |
| Capital Expenditures | n/a |
| Free Cash Flow | -155.86M |
| FCF Per Share | -1.59 |
Full Cash Flow StatementMargins
Gross margin is 100%, with operating and profit margins of -241678.95% and -80507.89%.
| Gross Margin | 100% |
| Operating Margin | -241678.95% |
| Pretax Margin | -215701.32% |
| Profit Margin | -80507.89% |
| EBITDA Margin | -209982.89% |
| EBIT Margin | -241678.95% |
| FCF Margin | -205078.95% |
